Results 111 to 120 of about 5,687 (195)

Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – A case report

eJHaem
The use of Bruton's tyrosine kinase inhibitors (BTKi) is rapidly increasing for patients with mantle cell lymphoma (MCL). Side effects reported so far are usually manageable.
Anna Nikkarinen, Ingrid Glimelius
doaj   +1 more source

Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma [PDF]

, 2017
Cerchione, Claudio, Ciancia, Giuseppe, DELLA PEPA, Roberta, DI PERNA, Maria, Giordano, Claudia, Intrieri, Mariano, Pane, Fabrizio, Picardi, Marco, Pugliese, Novella, Raimondo, Marta, Troncone, Giancarlo, Zacheo, Irene   +11 more
core   +1 more source

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia [PDF]

, 2017
C. J. Owen, C. L. Toze, C. Shustik, I. Bence-Bruckler, R. Delage, S. Coutre   +5 more
core   +1 more source

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma [PDF]

, 2020
al., et, Bartlett, Nancy L., Cashen, Amanda, Edwin, Natasha, Ghobadi, Armin, Kahl, Brad, Mehta-Shah, Neha, Merryman, Reid W.   +7 more
core   +1 more source

Outbreak of immediate-type hydrolyzed wheat protein allergy due to a facial soap in Japan [PDF]

, 2017
Aihara Michiko, Chinuki Yuko, Fukushima Atsuki, Fukutomi Yuma, Hide Michihiro, Ikezawa Zenro, Itagaki Yasuharu, Kato Zenichiro, Kishikawa Reiko, Matsunaga Kayoko, Morita Eishin, Nakamura Masashi, Noguchi Emiko, Saito Hirohisa, Sugiura Shin-ichi, Tanaka Hiroyuki, Teshima Reiko, Urisu Atsuo, Yagami Akiko, 野口 惠美子   +19 more
core   +2 more sources

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study. [PDF]

, 2021
Calvo, R, De Vos, S, Dyer, MJS, Flowers, CR, Frigault, MM, Maddocks, KJ, Patel, P, Ruan, J, Rule, S, Strati, P, Wei, H, Xu, Y   +11 more
core   +2 more sources

Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats [PDF]

, 2023
Aimaretti, Eleonora, Alves, Gustavo Ferreira, Collino, Massimo   +2 more
core   +1 more source

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL. [PDF]

Blood Adv
Shadman M, Tam CS, Brander DM, Lefebure M, Yang K, Xu S, Tian T, Kuptsova-Clarkson N, Williams R, Hirata J, Munir T.   +10 more
europepmc   +1 more source

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy [PDF]

, 2018
Coats, Josh, Collins, Graham P., Cross, Matthew, Dyer, Martin J. S., Eyre, Toby A., Follows, George, Fox, Christopher P., Hodson, Andrew, Iyengar, Sunil, Morley, Nick, Narat, Santosh, Walter, Harriet S.   +11 more
core   +3 more sources

Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies. [PDF]

Cell Biol Toxicol
Wang P, Fu H, Wu J, Li R, Cao L, Xu RA, Lin W.   +6 more
europepmc   +1 more source